PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Strategic Analysis of the Global Markets for Lutein in Human Nutrition - New analysis from Frost & Sullivan (food.frost.com), Strategic Analysis of the Global Markets for Lutein in Human Nutrition, reveals that this market earned revenues of $105.1 million in 2006 and estimates this to reach $124.5 million in 2013
Strategic Analysis of the Global Markets for Lutein in Human Nutrition

 

NewswireToday - /newswire/ - London, United Kingdom, 2007/06/19 - New analysis from Frost & Sullivan (food.frost.com), Strategic Analysis of the Global Markets for Lutein in Human Nutrition, reveals that this market earned revenues of $105.1 million in 2006 and estimates this to reach $124.5 million in 2013.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Eye Health Concerns Key Driver of Lutein Market but Emerging Applications and Geographical Markets Hold Key to Growth

A growing and exhaustive body of scientific evidence supporting lutein’s eye health benefits is the primary reason driving the growth of this market globally. Several studies have documented the beneficial effects of eating a diet rich in lutein, such as reducing the risk of age-related macular degeneration (AMD) and cataract and even slowing the progression of the disease. This augurs well for the global lutein market, given that eye health ranks among the top five health concerns in the United States, as well as in various countries across the European Union (EU).

“One of the more important studies currently being carried out in this regard is the Age-Related Eye Disease Study 2 (AREDS2), which specifically examines the effect of oral supplementation of lutein and zeaxanthin and omega-3 long chain polyunsaturated fatty acids on the prevention of advanced AMD and cataract,” says Team Leader Ashwin Sukumaran for Frost & Sullivan’s North American Food and Beverage Ingredients Practice. “Industry participants believe that this study will provide definitive proof, if further is needed, of lutein’s benefits in eye health.”

New analysis from Frost & Sullivan (food.frost.com), Strategic Analysis of the Global Markets for Lutein in Human Nutrition, reveals that this market earned revenues of $105.1 million in 2006 and estimates this to reach $124.5 million in 2013.

If you are interested in a virtual brochure, which provides manufacturers, end users and other industry participants with a strategic overview of the Global Lutein Market, then send an email to Vanessa Quezada, Corporate Communications, at vanessa.quezada[.]frost.com with your full name, company name, title, telephone number and email address. An overview will be sent to you via email upon receipt of the above information.

However, the market now faces a considerable challenge in the growing maturity of dietary supplements, its key end-user application segment. This application accounts for more than 90 percent of lutein volumes, but its major markets, Europe and the United States, are exhibiting growth rates of only 2 to 3 percent per year.

Manufacturers need to address this growing maturity in dietary supplements by identifying new and potentially lucrative application segments that offer opportunities for the continued growth of the lutein market. A solid body of research supporting lutein’s benefits in other emerging areas such as skin health, could allow manufacturers to penetrate the promising cosmeceutical application segment.

“Recent research into new application segments for lutein, such as skin health, is creating a lot of excitement in this industry,” says Mr. Sukumaran. “Building a strong scientific case for lutein’s benefits in skin health would allow it to break into the lucrative, high-growth cosmeceutical application segment and help boost the market.”

Compliance with legislation is another major challenge, perhaps the most significant, across the supplement ingredients markets, and this invariably varies between countries and regions. The EU and the United States have clear directives governing the use of lutein in dietary supplements and functional foods. However, this is not the case in Asia where nutraceuticals and functional foods are largely unregulated while dietary supplements are regulated either as drugs or food, depending on the legislation in individual countries.

Legislative requirements place considerable pressure on any ingredient manufacturers resource. Manufacturers must carry the burden of proof when marketing a new ingredient or launching a product. This can range from technical knowledge and testing to legal knowledge.

The situation becomes more complex when the manufacturer has a worldwide presence and launches the product in different geographical markets. In the case that a lutein manufacturer wants to supply both the US and European markets, it has to satisfy not only US standards, but EU regulations as well. Regulations of individual member states in the EU also have to be met, and a manufacturer supplying to the Asian market has to deal with more complexities.

“Currently, countries such as India, China and Vietnam are tightening their regulations, and with more national markets introducing regulations, the implications for lutein manufacturers are severe,” says Sukumaran. “The technology, knowledge and certification process required to meet the demands of the European and US pharmacopoeia, as well as the new Asian markets, are expected to be a considerable challenge to this industry, having a medium impact throughout the forecast period.”

Strategic Analysis of the Global Markets for Lutein in Human Nutrition is part of the Food & Beverage Ingredients Growth Partnership Service program, which also includes research in the following: the U.S. Essential Oils and Oleoresins Market, the U.S. Polyols Markets, and the European Colours Market. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies and the investment community by providing comprehensive industry coverage that reflects a unique global perspective, and combines ongoing analysis of markets, technologies, econometrics and demographics.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Strategic Analysis of the Global Markets for Lutein in Human Nutrition

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan |
Publisher Contact: Vanessa Quezada 
210.477.8427 vanessa.quezada[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application
Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  NAKIVO, Inc.





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)